Skip to main content

Table 3 The relationship between GSTM1 genotypes and microangiopathic complications in diabetic patients

From: Evaluation of glutathione S-transferase polymorphism in Iranian patients with type 2 diabetic microangiopathy

Groups/variables Null Wild P value
DM without DR vs. DM with DR 13/97 (13.4)
7/109 (6.42)
84/97 (86.6)
102/109 (93.58)
0.073
DM without DN vs. DM with DN 9/149 (6.04)
11/57 (19.3)
140/149 (93.96)
46/57 (80.7)
0.006
DM without DNp vs. DM with DNp 9/104 (8.65)
11/102 (10.78)
95/104 (91.35)
91/102 (89.22)
0.389
DM without DNa vs. DM with DNa 13/146 (8.9)
7/60 (11.67)
133/146 (91.1)
53/60 (88.33)
0.354
DM without microangiopathy vs. DM with microangiopathy 4/72 (5.56)
16/134 (11.94)
68/72 (94.44)
118/134 (88.06)
0.107
Control vs. DM 15/114 (13.16)
20/206 (9.7)
99/114 (86.84)
186/206 (90.3)
0.222
  1. DM diabetes mellitus; DR diabetic retinopathy; DN diabetic nephropathy; DNp peripheral diabetic neuropathy; DNa autonomic diabetic neuropathy
  2. The data are expressed as in n (%)